COVID-19
The Centers for Disease Control and Prevention (CDC) has recommended an additional dose of mRNA COVID-19 vaccine for people who are moderately to severely immunocompromised. This recommendation is based on the effectiveness of messenger RNA (mRNA) vaccines, such as those developed by Pfizer Inc. and Moderna Inc., in providing instructions
Pharmaceutical industry
The global Chronic Kidney Disease (CKD) drugs market is projected to grow significantly, driven by the increasing prevalence of CKD and the launch of new drugs. Amid the COVID-19 crisis, the market is estimated to reach $15.5 billion by 2026, growing at a CAGR of 1.9% over the
COVID-19
A study published on medrxiv.org has found that a third vaccination improves humoral immunity against COVID-19 in cancer patients on active chemotherapy, with no severe adverse events. The research, which has not been peer-reviewed, involved 20 participants who received a third booster shot as part of an interventional phase
COVID-19
The administration's ambitious plan to start booster shots for most Americans by September 20 faces a significant hurdle, with Moderna's vaccine facing potential delays due to inadequate data. The Centers for Disease Control and Prevention and the Food and Drug Administration are awaiting critical data before
Pharmaceutical industry
Businesses, encouraged by the U.S. Food and Drug Administration's recent full approval of Pfizer's COVID-19 vaccine, are increasingly requiring workers to get vaccinated or face consequences, such as being fired or charged extra for health insurance. Employers feel that a significant push is needed to
Pharmaceutical industry
As the world grapples with the ongoing pandemic, a new report by Global Industry Analysts Inc. provides a comprehensive analysis of the COVID-19 vaccines market, highlighting trends, opportunities, and challenges. The report, "COVID-19 Vaccines - Global Market Trajectory & Analytics," offers a fresh perspective on the post-COVID-19 marketplace,
COVID-19
Hy-Vee, Inc. has announced that it will host COVID-19 and flu vaccination clinics at the South Dakota State Fair, which begins on Thursday, September 2. The vaccination clinics will be held daily from noon-4 p.m. from September 2 to September 6, with no appointment necessary. Hy-Vee pharmacy team members
Pfizer Inc.
As the US Food and Drug Administration (FDA) grants full approval to Pfizer's COVID-19 vaccine, employers are swiftly moving to require workers to get vaccinated, citing the need to protect employees, customers, and the wider community. The FDA's decision, made public on Monday, has removed a
Pfizer Inc.
As the full US authorisation of the Pfizer coronavirus vaccine drew near, the federal Food and Drug Administration (FDA) took a firm stance against the use of ivermectin, a medicine used to deworm livestock, for COVID-19 treatment. The agency's simple yet emphatic message to Americans was: "You
Pharmaceutical industry
The global market for anti-inflammatory therapeutics is projected to reach $130.9 billion by 2026, growing at a compound annual growth rate (CAGR) of 4.8% over the analysis period. The market is expected to experience significant growth due to the increasing prevalence of chronic inflammatory diseases, such as arthritis,
COVID-19
The Biden administration has announced a recommendation for Covid-19 vaccine boosters, citing concerns over the highly infectious Delta variant and decreasing vaccine effectiveness over time. This decision comes despite the lack of FDA and CDC guidance or authorization for booster candidates in the general population. According to the White House,
COVID-19
Amidst the ongoing COVID-19 crisis, the global market for Active Pharmaceutical Ingredients/API is poised for significant growth, driven by the increasing demand for innovative and generic pharmaceutical products. The market, valued at $204.2 Billion in 2020, is expected to reach $274.8 Billion by 2026, growing at a
